Ezrin, has been investigated in a large study of ovarian cancerwhere its expression was reduced in 440 ovarian cancer samples compared to normaland lower expression was associated with higher grade and shorter survival althoughnot in a multivariate analysis [66]. The gene discussed is EZR; the disease is ovarian carcinoma.